Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 84

Results For "cost"

1278 News Found

Granules India chooses Veeam to protect digital business
Digitisation | May 30, 2022

Granules India chooses Veeam to protect digital business

Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours


Venus Remedies registers 9.22 % growth in annual sales for FY22
News | May 29, 2022

Venus Remedies registers 9.22 % growth in annual sales for FY22

The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal


MVA-BN respiratory syncytial virus vaccine could get first-to-market opportunity in China, says GlobalData
Biotech | May 29, 2022

MVA-BN respiratory syncytial virus vaccine could get first-to-market opportunity in China, says GlobalData

RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised


CorePath partners with Cizzle Bio to develop blood test to detect lung cancer
Biotech | May 27, 2022

CorePath partners with Cizzle Bio to develop blood test to detect lung cancer

Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths


DFE Pharma opens its new Center of Excellence in Hyderabad, India
News | May 27, 2022

DFE Pharma opens its new Center of Excellence in Hyderabad, India

The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs


TN govt. hospital performs robotic-assisted surgery
Hospitals | May 26, 2022

TN govt. hospital performs robotic-assisted surgery

The Da Vinci Robotic-Assisted Surgery system, and Advanced Robotic Surgery Centre was inaugurated early this year


Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities
News | May 26, 2022

Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities

ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E


Thyrocare launches its Regional Processing Lab in Nagpur on World Thyroid Day
Clinical Trials | May 25, 2022

Thyrocare launches its Regional Processing Lab in Nagpur on World Thyroid Day

The new advanced regional processing lab will serve Nagpur city and the Vidarbha region


My aim is to help the pharmaceutical industry develop a winning strategy: Dr Rupali Paranjape
interviews | May 23, 2022

My aim is to help the pharmaceutical industry develop a winning strategy: Dr Rupali Paranjape

Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com


50% of the world's population expected to be myopic by 2050
News | May 23, 2022

50% of the world's population expected to be myopic by 2050

Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear